98%
921
2 minutes
20
Purpose: One of the main pathophysiological mechanisms of chronic obstructive pulmonary disease is inflammation, which has been associated with lymphadenopathy. Intrapulmonary lymph nodes can be identified on CT as perifissural nodules (PFN). We investigated the association between the number and size of PFNs and measures of COPD severity.
Materials And Methods: CT images were obtained from COPDGene. 50 subjects were randomly selected per GOLD stage (0 to 4), GOLD-unclassified, and never-smoker groups and allocated to either "Healthy," "Mild," or "Moderate/severe" groups. 26/350 (7.4%) subjects had missing images and were excluded. Supported by computer-aided detection, a trained researcher prelocated non-calcified opacities larger than 3 mm in diameter. Included lung opacities were classified independently by two radiologists as either "PFN," "not a PFN," "calcified," or "not a nodule"; disagreements were arbitrated by a third radiologist. Ordinal logistic regression was performed as the main statistical test.
Results: A total of 592 opacities were included in the observer study. A total of 163/592 classifications (27.5%) required arbitration. A total of 17/592 opacities (2.9%) were excluded from the analysis because they were not considered nodular, were calcified, or all three radiologists disagreed. A total of 366/575 accepted nodules (63.7%) were considered PFNs. A maximum of 10 PFNs were found in one image; 154/324 (47.5%) contained no PFNs. The number of PFNs per subject did not differ between COPD severity groups ( = 0.50). PFN short-axis diameter could significantly distinguish between the Mild and Moderate/severe groups, but not between the Healthy and Mild groups ( = 0.021).
Conclusions: There is no relationship between PFN count and COPD severity. There may be a weak trend of larger intrapulmonary lymph nodes among patients with more advanced stages of COPD.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337033 | PMC |
http://dx.doi.org/10.7717/peerj.9166 | DOI Listing |
Ultrastruct Pathol
September 2025
University of South Alabama, Mobile, Alabama, USA.
Diffuse intrapulmonary malignant mesothelioma (DIMM) is a rare variant of epithelioid mesothelioma characterized by diffuse lung parenchymal involvement without a discrete pleural mass, often mimicking interstitial lung disease (ILD). We report a case of a 55-year-old male presenting with bilateral pleural effusions and a complex clinical course requiring multiple thoracic interventions. Histology revealed scattered nests of epithelioid tumor cells in the lung interstitium and lymph nodes, with immunohistochemistry positive for mesothelial markers (calretinin, WT1, D2-40) and negative for carcinoma markers.
View Article and Find Full Text PDFClin Nucl Med
July 2025
Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Background: Prostate-specific membrane antigen (PSMA), expressed in neovascular endothelial cells of various malignancies including lung cancer (LC), highlights its potential as a biomarker for neovascularization. This study aimed to investigate the diagnostic efficacy of PSMA PET/CT in primary lung cancer (PLC), as well as to explore its role in staging and neovascularization detection in PLC.
Patients And Methods: This retrospective study included 39 patients (27 with PLC, 12 with benign lesions) who underwent PSMA PET/CT, with or without FDG PET/CT, between April 2021 and July 2024.
J Control Release
July 2025
School of Pharmacy, Shenyang Key Laboratory of Intelligent Mucosal Drug Delivery Systems, Shenyang Pharmaceutical University, Shenyang 110016, China; Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang 110016, China. Electronic address: maosh
Stimulating respiratory immunity helps protect from infection, mitigate disease severity, and curtail transmission. Nonetheless, the majority of current nanovaccines are unable to elicit strong mucosal and systemic immunity owing to suboptimal formulations. Inspired by natural pathogens, we developed virus-like biomimetic nanovaccines in which the heparan sulfate-modified liposome layer (SH-Lip) mimics the "capsid", while platycodin with varying glycosyl side chain structures (PD, PD3, PE) functions as the exposed "spike proteins" to boost immune response and antigen delivery.
View Article and Find Full Text PDFSemin Ultrasound CT MR
September 2025
Satsuma Lab, Hawkes Institute, University College London, London, UK; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
This review summarizes the 3 components of the pulmonary lymphatic system: lymphatic channels, bronchus-associated lymphoid tissue (BALT), and intrapulmonary lymph nodes. Lymphatic vessels are distributed within the bronchovascular bundles, in the interlobular septa and visceral pleura, and around small pulmonary arteries and veins within the secondary pulmonary lobules. Normally invisible on CT, they may appear with lymphatic dilation or disease spreading via lymphatic routes.
View Article and Find Full Text PDFRespir Med Case Rep
April 2025
Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuan Jiagang, Yuzhong District, Chongqing, 400016, China.
Primary malignant melanoma of lung (PMML) are relatively rare, accounting for about 0.4 % of all malignant melanomas and only 0.01 % of all lung tumors, and PMML with distant metastases found at diagnosis is extremely rare.
View Article and Find Full Text PDF